Abstract:Immunotherapy for bladder cancer is prevalent, while the efficacy is uncertain. To predict the outcomes of immunotherapy in bladder cancer patients, we had delineated the landscape of the tumor immune microenvironment based on two independent public databases, classified the bladder cancers in the training cohort as well as the validating cohort into the immune high and immune low subtypes, and identified 23 differentially expressed immune-related genes between the two subtype patients to build a prognostic ge… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.